Search

Search results

1. The Misguided War against Medicines 2011

   Government spending on all types of prescription drugs (patented and non-patented) is increasing faster than any other component of health spending. And new or patented medicines tend to be more expensive compared to older drugs and other health ...

2. The Misguided War Against Medicines 2010

   The Misguided War against Medicines 2010 examines all of the ways in which spending on drugs may contribute to the overall growth in total government health spending. The evidence suggests that neither patented medicines in particular, nor prescription ...

3. Cost Burden of Prescription Drug Spending in Canada and the United States, 2008 Edition

   There is a common misconception that American prices for prescription medications are excessive because they are often higher than prices in Canada. This leads some people to suggest that the overall cost burden of prescription drug spending in the United ...

4. Seniors and Drug Prices in Canada and the United States, 2008 Edition

   This is the Fraser Institute's third report comparing Canada-US price differences for the prescription drugs that are most important to Canadian seniors (aged 60 and older). This year's report analyzes prices for the drugs most commonly ...

5. The Misguided War Against Medicines 2008

   Government spending on all types of prescription drugs (patented and non-patented) is increasing faster than any other component of health spending. And new or patented medicines tend to be more expensive compared to older drugs and other health ...

6. Seniors and Drug Prices in Canada and the United States

   This paper compares Canada-US price differences for the drugs that were most important to Canadian seniors (aged 60 and older) in 2006. Prices are compared separately for brand name and generic prescription drugs. https://www.fraserinstitute.org/sites ...

7. The Misguided War Against Medicines 2007

   Government spending on all types of prescription drugs (patented and non-patented) is increasing faster than any other component of health spending. And new or patented medicines tend to be more expensive compared to older drugs and other health ...